Cyclosporine absorption profiling and therapeutic drug monitoring using C2 blood levels in stable renal allograft recipients

被引:18
作者
Einecke, G
Mai, I
Diekmann, F
Fritsche, L
Neumayer, HH
Budde, K
机构
[1] Humboldt Univ, Dept Nephrol, Charite, D-10098 Berlin, Germany
[2] Humboldt Univ, Dept Clin Pharmacol, Charite, D-10098 Berlin, Germany
关键词
D O I
10.1016/S0041-1345(02)03003-8
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
引用
收藏
页码:1738 / 1739
页数:2
相关论文
共 11 条
[1]  
COLE E, 2001, AM J TRANSPLANT, V1, P386
[2]   Limited sampling strategies for estimating cyclosporin area under the concentration-time curve: Review of current algorithms [J].
David, OJ ;
Johnston, A .
THERAPEUTIC DRUG MONITORING, 2001, 23 (02) :100-114
[3]   Abbreviated kinetic profiles in area-under-the-curve monitoring of cyclosporine therapy - Technical Note [J].
Gaspari, F ;
Perico, N ;
Signorini, O ;
Caruso, R ;
Remuzzi, G .
KIDNEY INTERNATIONAL, 1998, 54 (06) :2146-2150
[4]   The temporal profile of calcineurin inhibition by cyclosporine in vivo [J].
Halloran, PF ;
Helms, LMH ;
Kung, L ;
Noujaim, J .
TRANSPLANTATION, 1999, 68 (09) :1356-1361
[5]   CHALLENGES IN CYCLOSPORINE THERAPY - THE ROLE OF THERAPEUTIC MONITORING BY AREA-UNDER-THE-CURVE MONITORING [J].
KAHAN, BD ;
WELSH, M ;
RUTZKY, LP .
THERAPEUTIC DRUG MONITORING, 1995, 17 (06) :621-624
[6]   OPTIMIZATION OF CYCLOSPORINE THERAPY IN RENAL-TRANSPLANTATION BY A PHARMACOKINETIC STRATEGY [J].
KAHAN, BD ;
GREVEL, J .
TRANSPLANTATION, 1988, 46 (05) :631-644
[7]  
KAISKE BL, 1988, TRANSPLANTATION, V46, P716
[8]   A randomized, prospective multicenter pharmacoepidemiologic study of cyclosporine microemulsion in stable renal graft recipients [J].
Keown, P ;
Landsberg, D ;
Halloran, P ;
Shoker, A ;
Rush, D ;
Jeffery, J ;
Russell, D ;
Stiller, C ;
Muirhead, N ;
Cole, E ;
Paul, L ;
Zaltzman, J ;
Loertscher, R ;
Daloze, P ;
Dandavino, R ;
Boucher, A ;
Handa, P ;
Lawen, J ;
Belitsky, P ;
Parfrey, P .
TRANSPLANTATION, 1996, 62 (12) :1744-1752
[9]  
Keown PA, 2002, AM J TRANSPLANT, V2, P157
[10]   C2 monitoring strategy for optimising cyclosporin immunosuppression from the neoral®1 formulation [J].
Levy, GA .
BIODRUGS, 2001, 15 (05) :279-290